| The role of C-reactive protein as a prognostic indicator in advanced cancer FA Mahmoud, NI Rivera Current oncology reports 4, 250-255, 2002 | 411 | 2002 |
| Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma S Kakadia, N Yarlagadda, R Awad, M Kundranda, J Niu, B Naraev, ... OncoTargets and therapy, 7095-7107, 2018 | 271 | 2018 |
| Established and potential therapeutic applications of cannabinoids in oncology D Walsh, KA Nelson, F Mahmoud Supportive Care in Cancer 11, 137-143, 2003 | 267 | 2003 |
| Evaluation of nutritional status in advanced metastatic cancer N Sarhill, F Mahmoud, D Walsh, KA Nelson, S Komurcu, M Davis, ... Supportive care in cancer 11, 652-659, 2003 | 207 | 2003 |
| Principles and practice of palliative care and supportive oncology AM Berger, JL Shuster, JH Von Roenn Lippincott Williams & Wilkins, 2007 | 203 | 2007 |
| Assessment of nutritional status and fluid deficits in advanced cancer N Sarhill, FA Mahmoud, R Christie, A Tahir American Journal of Hospice and Palliative Medicine® 20 (6), 465-473, 2003 | 112 | 2003 |
| Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index D Walsh, F Mahmoud, B Barna Supportive Care in Cancer 11, 60-62, 2003 | 104 | 2003 |
| Indicators of responsiveness to immune checkpoint inhibitors BD Shields, F Mahmoud, EM Taylor, SD Byrum, D Sengupta, B Koss, ... Scientific reports 7 (1), 807, 2017 | 95 | 2017 |
| Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors B Firwana, R Ravilla, M Raval, L Hutchins, F Mahmoud Journal of Oncology Pharmacy Practice 23 (8), 620-624, 2017 | 79 | 2017 |
| Respiratory function during parenteral opioid titration for cancer pain B Estfan, F Mahmoud, P Shaheen, MP Davis, W Lasheen, N Rivera, ... Palliative Medicine 21 (2), 81-86, 2007 | 78 | 2007 |
| Loss of E-cadherin inhibits CD103 antitumor activity and reduces checkpoint blockade responsiveness in melanoma BD Shields, B Koss, EM Taylor, AJ Storey, KL West, SD Byrum, ... Cancer research 79 (6), 1113-1123, 2019 | 63 | 2019 |
| Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack F Mahmoud, B Shields, I Makhoul, N Avaritt, HK Wong, LF Hutchins, ... Cancer biology & therapy 18 (7), 451-469, 2017 | 62 | 2017 |
| A phase II dose titration study of thalidomide for cancer-associated anorexia M Davis, W Lasheen, D Walsh, F Mahmoud, L Bicanovsky, R Lagman Journal of pain and symptom management 43 (1), 78-86, 2012 | 60 | 2012 |
| Role of EZH2 histone methyltrasferase in melanoma progression and metastasis F Mahmoud, B Shields, I Makhoul, LF Hutchins, SC Shalin, AJ Tackett Cancer biology & therapy 17 (6), 579-591, 2016 | 57 | 2016 |
| Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: a case report and review of literature AO Abdallah, A Herlopian, R Ravilla, M Bansal, S Chandra-Reddy, ... Journal of Oncology Pharmacy Practice 22 (3), 537-542, 2016 | 51 | 2016 |
| Response to idelalisib in a patient with stage IV Merkel-cell carcinoma MB Shiver, F Mahmoud, L Gao New England Journal of Medicine 373 (16), 1580-1582, 2015 | 50 | 2015 |
| Cancer patient perspectives regarding preparedness for end-of-life care: A qualitative study AC Sherman, S Simonton-Atchley, CW Mikeal, KM Anderson, ... Journal of Psychosocial Oncology 36 (4), 454-469, 2018 | 41 | 2018 |
| Anti-angiogenesis revisited: combination with immunotherapy in solid tumors A Chambers, M Kundranda, S Rao, F Mahmoud, J Niu Current Oncology Reports 23, 1-9, 2021 | 38 | 2021 |
| Methylphenidate side effects in advanced cancer: a retrospective analysis W Lasheen, D Walsh, F Mahmoud, MP Davis, N Rivera, DS Khoshknabi American Journal of Hospice and Palliative Medicine® 27 (1), 16-23, 2010 | 38 | 2010 |
| Thrombotic thrombocytopenic purpura due to checkpoint inhibitors A Youssef, N Kasso, AS Torloni, M Stanek, T Dragovich, M Gimbel, ... Case reports in hematology 2018 (1), 2464619, 2018 | 37 | 2018 |
